Advertisement

Topics

Chiltern Company Profile

22:34 EDT 24th September 2017 | BioPortfolio

Established in 1982, Chiltern is a leading global Contract Research Organization with extensive experience conducting and staffing international Phase I to Phase IV clinical trials across a broad range of therapeutic areas for a wide variety of clients. Chiltern has conducted trials in more than 40 countries, has 24 offices and legal entities within 20 countries, resources in 37 countries and employs nearly 1,400 people globally. Chiltern provides Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions services. Further information: www.chiltern.com.


News Articles [39 Associated News Articles listed on BioPortfolio]

LabCorp to acquire Chiltern for $1.2B in cash

LabCorp, a global life sciences company, and Chiltern, a specialty CRO, announced that LabCorp will acquire Chiltern pursuant to a definitive agreement with Chiltern’s shareholders in an all-cash tr...

LabCorp to Acquire Specialty CRO Chiltern for $1.2 Billion in Cash

BURLINGTON, N.C. & WILMINGTON, N.C. & LONDON–(BUSINESS WIRE)–LabCorp® (NYSE:LH), a leading global life sciences company, and Chiltern, a specialty CRO, announced today that LabCor...

Chiltern acquisition improves competitiveness of offerings, says Covance CEO

LabCorp has acquired Chiltern for $1.2bn to create a global contract research organization (CRO) with more than 20,000 employees.

Chiltern acquires Japanese CRO

Chiltern has acquired Integrated Development Associates Co. Ltd. (IDA), a Japenese contract research organization (CRO) with offices in Japan, Korea, and Southeast Asia.

LabCorp pays $1.2bn in cash for Chiltern

Laboratory Corp. of America Holdings paid $1.2bn in cash for fellow CRO, privately held Chiltern International Ltd.

LabCorp completes acquisition of Chiltern for $1.2bn

US-based global life sciences company LabCorp has completed the acquisition of Chiltern, a specialist contract research organisation (CRO), for approximately $1.2bn.

LabCorp to acquire clinical trials firm Chiltern for $1.2bn

LabCorp has agreed to acquire specialty contract research organization (CRO) Chiltern for nearly $1.2bn in an all-cash deal to expand its oncology offerings.

LabCorp to buy Chiltern for approximately $1.2bn

US-based global life sciences company LabCorp is set to acquire Chiltern, a specialist contract research organisation (CRO), in an all-cash transaction valued at approximately $1.2bn.

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Chiltern

Established in 1982, Chiltern is a leading global Contract Research Organization with extensive experience conducting and staffing international Phase I to Phase IV clinical trials across a broad rang...

Chiltern International Limited

Established in 1982, Chiltern has amassed extensive experience in running trials from Phase I to Phase IV and across a broad therapeutic range. And with offices throughout Europe and in North America,...

Chiltern International

More Information about "Chiltern" on BioPortfolio

We have published hundreds of Chiltern news stories on BioPortfolio along with dozens of Chiltern Clinical Trials and PubMed Articles about Chiltern for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chiltern Companies in our database. You can also find out about relevant Chiltern Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Corporate Database Quicklinks



Searches Linking to this Company Record